{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:45:26Z","timestamp":1785782726529,"version":"3.56.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2023\/039\/RO5+6\/Seed-Mar\/04"],"award-info":[{"award-number":["NUHSRO\/2023\/039\/RO5+6\/Seed-Mar\/04"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","award":["OFLCG18May-0003"],"award-info":[{"award-number":["OFLCG18May-0003"]}],"id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","award":["OFLCG18May-0003"],"award-info":[{"award-number":["OFLCG18May-0003"]}],"id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Triple-negative breast cancer (TNBC) is a clinically aggressive subtype lacking targeted therapies, often characterized by hyperactivation of the Wnt\/\u03b2-catenin signaling pathway and an enriched population of cancer stem cells (CSCs). Here, we identify the DEAD-box RNA helicase DP103 as a novel modulator of Wnt\/\u03b2-catenin signaling in TNBC, acting independently of its canonical helicase function. DP103 expression correlates with increased phosphorylation of LRP6 and nuclear \u03b2-catenin accumulation, enhancing Wnt transcriptional activity. Mechanistically, DP103 physically interacts with GSK3\u03b2 to facilitate post-translational modifications essential for Wnt activation. Notably, DP103 itself is a Wnt target, forming a feedforward loop that sustains oncogenic signaling. Functional studies reveal that DP103 promotes CSC-like traits in TNBC cells, including self-renewal and expression of stemness markers (Nanog, Oct4, Sox2), linking its role in Wnt activation to breast cancer stemness and metastasis. In vivo studies using Drosophila models confirmed the evolutionarily conserved role of Gemin3\/DP103 in epithelial transformation, though context-dependent differences were observed. Importantly, we demonstrate that RX-5902, a Wnt pathway inhibitor currently in clinical trials, suppresses DP103 expression and Wnt\/\u03b2-catenin signaling, reducing TNBC cell viability and mammosphere formation without affecting normal epithelial cells. RX-5902 efficacy was abrogated by DP103 depletion, underscoring DP103\u2019s critical role in mediating drug response. In xenograft models, RX-5902 treatment significantly reduced tumor burden and prolonged survival. Collectively, our findings establish DP103 as a key regulator of Wnt-driven oncogenesis in TNBC and highlight its dual role in promoting CSC traits and therapeutic resistance. These insights position DP103 as a potential biomarker and therapeutic target to disrupt sustained Wnt signaling in TNBC, offering new avenues for precision intervention in this challenging breast cancer subtype.<\/jats:p>","DOI":"10.1038\/s41419-026-08943-3","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:05:22Z","timestamp":1780632322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DP103 as a critical modulator of Wnt signaling and cancer stemness: implications for precision treatment in triple negative breast cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Wanpei","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4294-9498","authenticated-orcid":false,"given":"Sebastian \u00d6ther-Gee","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianning","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiu Yan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharine Shi-Yun","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1799-0392","authenticated-orcid":false,"given":"Mark","family":"Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arindam","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawat","family":"Bunnag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahnavi","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amudha","family":"Deivasigamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6624-1593","authenticated-orcid":false,"given":"Tuan Zea","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthukumar","family":"Rajasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Lee Foon","family":"Swa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San Hue","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0726-9128","authenticated-orcid":false,"given":"Shiyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet Cheng-Fei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jas Min","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn Yeen Hui","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aye Aye","family":"Thike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu Mathi","family":"Kanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Keung","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-3185","authenticated-orcid":false,"given":"Ruby Yun-Ju","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5377-6537","authenticated-orcid":false,"given":"Jayantha","family":"Gunaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-7865","authenticated-orcid":false,"given":"Melissa Jane","family":"Fullwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puay Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8677-8475","authenticated-orcid":false,"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8525-0209","authenticated-orcid":false,"given":"Jeremy P.","family":"Blaydes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestial T.","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8445-184X","authenticated-orcid":false,"given":"Peter Edward","family":"Lobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venetia Jing-Tong","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunasalam","family":"Dharmarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam Man","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deog Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2658-5436","authenticated-orcid":false,"given":"Jit Kong","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Tolwinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Peng","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8017-1093","authenticated-orcid":false,"given":"Kevin B.","family":"Myant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3754-5712","authenticated-orcid":false,"given":"Alan Prem","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"8943_CR1","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Investig. 2011;121:2750\u201367.","journal-title":"J Clin Investig"},{"key":"8943_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3816\/CBC.2009.n.005","volume":"9","author":"F Kassam","year":"2009","unstructured":"Kassam F, Enright K, Dent R, Dranitsaris G, Myers J, Flynn C, et al. Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design. Clin Breast Cancer. 2009;9:29\u201333.","journal-title":"Clin Breast Cancer"},{"key":"8943_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fphys.2013.00225","volume":"4","author":"TW Owens","year":"2013","unstructured":"Owens TW, Naylor MJ. Breast cancer stem cells. Front Physiol. 2013;4:225.","journal-title":"Front Physiol"},{"key":"8943_CR4","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 2010;12:R68.","journal-title":"Breast Cancer Res"},{"key":"8943_CR5","doi-asserted-by":"crossref","unstructured":"Sabatier R, Finetti P, Guille A, Adelaide J, Chaffanet M, Viens P, et al. Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization. Mol Cancer. 2014; 13:228.","DOI":"10.1186\/1476-4598-13-228"},{"key":"8943_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrm3470","volume":"13","author":"C Niehrs","year":"2012","unstructured":"Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol. 2012;13:767\u201379.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8943_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.14","volume":"6","author":"SG Pohl","year":"2017","unstructured":"Pohl SG, Brook N, Agostino M, Arfuso F, Kumar AP, Dharmarajan A. Wnt signaling in triple-negative breast cancer. Oncogenesis. 2017;6:e310.","journal-title":"Oncogenesis"},{"key":"8943_CR8","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.2353\/ajpath.2010.091125","volume":"176","author":"AI Khramtsov","year":"2010","unstructured":"Khramtsov AI, Khramtsova GF, Tretiakova M, Huo D, Olopade OI, Goss KH. Wnt\/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol. 2010;176:2911\u201320.","journal-title":"Am J Pathol"},{"key":"8943_CR9","doi-asserted-by":"publisher","first-page":"e0117097","DOI":"10.1371\/journal.pone.0117097","volume":"10","author":"J Xu","year":"2015","unstructured":"Xu J, Prosperi JR, Choudhury N, Olopade OI, Goss KH. Beta-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells. PLoS ONE. 2015;10:e0117097.","journal-title":"PLoS ONE"},{"key":"8943_CR10","first-page":"62","volume":"1795","author":"M Zilli","year":"2009","unstructured":"Zilli M, Grassadonia A, Tinari N, Di Giacobbe A, Gildetti S, Giampietro J, et al. Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer. Biochim Biophys Acta. 2009;1795:62\u201381.","journal-title":"Biochim Biophys Acta"},{"key":"8943_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/bcr2723","volume":"12","author":"A Incassati","year":"2010","unstructured":"Incassati A, Chandramouli A, Eelkema R, Cowin P. Key signaling nodes in mammary gland development and cancer: \u03b2-catenin. Breast Cancer Res. 2010;12:213.","journal-title":"Breast Cancer Res"},{"key":"8943_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep12465","volume":"5","author":"GB Jang","year":"2015","unstructured":"Jang GB, Kim JY, Cho SD, Park KS, Jung JY, Lee HY, et al. Blockade of Wnt\/beta-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype. Sci Rep. 2015;5:12465.","journal-title":"Sci Rep"},{"key":"8943_CR13","doi-asserted-by":"publisher","first-page":"e5813","DOI":"10.1371\/journal.pone.0005813","volume":"4","author":"C Lindvall","year":"2009","unstructured":"Lindvall C, Zylstra CR, Evans N, West RA, Dykema K, Furge KA, et al. The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. PloS one. 2009;4:e5813.","journal-title":"PloS one"},{"key":"8943_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/dneu.20851","volume":"71","author":"GY Yang","year":"2011","unstructured":"Yang GY, Luo ZG. Implication of Wnt signaling in neuronal polarization. Dev Neurobiol. 2011;71:495\u2013507.","journal-title":"Dev Neurobiol"},{"key":"8943_CR15","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1200\/JCO.2009.27.5388","volume":"28","author":"S Liu","year":"2010","unstructured":"Liu S, Wicha MS. Targeting breast cancer stem cells. J Clin Oncol. 2010;28:4006\u201312.","journal-title":"J Clin Oncol"},{"key":"8943_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/beta-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13:165.","journal-title":"J Hematol Oncol"},{"key":"8943_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","volume":"12","author":"N Takebe","year":"2015","unstructured":"Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12:445\u201364.","journal-title":"Nat Rev Clin Oncol"},{"key":"8943_CR18","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s13058-014-0496-5","volume":"16","author":"KK Guturi","year":"2014","unstructured":"Guturi KK, Sarkar M, Bhowmik A, Das N, Ghosh MK. DEAD-box protein p68 is regulated by beta-catenin\/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression. Breast Cancer Res. 2014;16:496.","journal-title":"Breast Cancer Res"},{"key":"8943_CR19","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gks1066","volume":"41","author":"KA Gray","year":"2013","unstructured":"Gray KA, Daugherty LC, Gordon SM, Seal RL, Wright MW, Bruford EA. Genenames.org: the HGNC resources in 2013. Nucleic Acids Res. 2013;41:D545\u201352.","journal-title":"Nucleic Acids Res"},{"key":"8943_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrm1335","volume":"5","author":"S Rocak","year":"2004","unstructured":"Rocak S, Linder P. DEAD-box proteins: the driving forces behind RNA metabolism. Nat Rev Mol Cell Biol. 2004;5:232\u201341.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8943_CR21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrc3107","volume":"11","author":"M van Kouwenhove","year":"2011","unstructured":"van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11:644\u201356.","journal-title":"Nat Rev Cancer"},{"key":"8943_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bbrc.2014.03.144","volume":"447","author":"KH Kim","year":"2014","unstructured":"Kim KH, Kang YJ, Jo JO, Ock MS, Moon SH, Suh DS, et al. DDX4 (DEAD box polypeptide 4) colocalizes with cancer stem cell marker CD133 in ovarian cancers. Biochem Biophys Res Commun. 2014;447:315\u201322.","journal-title":"Biochem Biophys Res Commun"},{"key":"8943_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","volume":"157","author":"TR Cech","year":"2014","unstructured":"Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell. 2014;157:77\u201394.","journal-title":"Cell"},{"key":"8943_CR24","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1093\/nar\/gkl460","volume":"34","author":"FV Fuller-Pace","year":"2006","unstructured":"Fuller-Pace FV. DExD\/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic acids Res. 2006;34:4206\u201315.","journal-title":"Nucleic acids Res"},{"key":"8943_CR25","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.1231499","volume":"339","author":"CM Cruciat","year":"2013","unstructured":"Cruciat CM, Dolde C, de Groot RE, Ohkawara B, Reinhard C, Korswagen HC, et al. RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-beta-catenin signaling. Science. 2013;339:1436\u201341.","journal-title":"Science"},{"key":"8943_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1042\/BST20180016","volume":"46","author":"F Curmi","year":"2018","unstructured":"Curmi F, Cauchi RJ. The multiple lives of DEAD-box RNA helicase DP103\/DDX20\/Gemin3. Biochem Soc Trans. 2018;46:329\u201341.","journal-title":"Biochem Soc Trans"},{"key":"8943_CR27","doi-asserted-by":"crossref","unstructured":"Cai W, Xiong Chen Z, Rane G, Satendra Singh S, Choo Z, Wang C, et al. Wanted DEAD\/H or alive: helicases winding up in cancers. J Natl Cancer Inst. 2017;109:djw278.","DOI":"10.1093\/jnci\/djw278"},{"key":"8943_CR28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2008.09.061","volume":"135","author":"L Zender","year":"2008","unstructured":"Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B, et al. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell. 2008;135:852\u201364.","journal-title":"Cell"},{"key":"8943_CR29","first-page":"810","volume":"33","author":"Y Guo","year":"2011","unstructured":"Guo Y, Zhang XG, Zhao N, Li TR, Li H. [Gemin3 inhibits cell apoptosis through suppression of p53 expression]. Zhonghua zhong liu za zhi [Chin J Oncol]. 2011;33:810\u20135.","journal-title":"Zhonghua zhong liu za zhi [Chin J Oncol]"},{"key":"8943_CR30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbrc.2012.03.034","volume":"420","author":"A Takata","year":"2012","unstructured":"Takata A, Otsuka M, Yoshikawa T, Kishikawa T, Kudo Y, Goto T, et al. A miRNA machinery component DDX20 controls NF-kappaB via microRNA-140 function. Biochem Biophys Res Commun. 2012;420:564\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"8943_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/hep.26011","volume":"57","author":"A Takata","year":"2013","unstructured":"Takata A, Otsuka M, Yoshikawa T, Kishikawa T, Hikiba Y, Obi S, et al. MicroRNA-140 acts as a liver tumor suppressor by controlling NF-kappaB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. Hepatology. 2013;57:162\u201370.","journal-title":"Hepatology"},{"key":"8943_CR32","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1172\/JCI73451","volume":"124","author":"EM Shin","year":"2014","unstructured":"Shin EM, Hay HS, Lee MH, Goh JN, Tan TZ, Sen YP, et al. DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Investig. 2014;124:3807\u201324.","journal-title":"J Clin Investig"},{"key":"8943_CR33","doi-asserted-by":"publisher","first-page":"e77425","DOI":"10.1371\/journal.pone.0077425","volume":"8","author":"N Dey","year":"2013","unstructured":"Dey N, Young B, Abramovitz M, Bouzyk M, Barwick B, De P, et al. Differential activation of Wnt-beta-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner. PLoS ONE. 2013;8:e77425.","journal-title":"PLoS ONE"},{"key":"8943_CR34","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.060025397","volume":"97","author":"SY Lin","year":"2000","unstructured":"Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA. 2000;97:4262\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8943_CR35","doi-asserted-by":"publisher","first-page":"E95","DOI":"10.1371\/journal.pbio.0020095","volume":"2","author":"NS Tolwinski","year":"2004","unstructured":"Tolwinski NS, Wieschaus E. A nuclear function for armadillo\/beta-catenin. PLoS Biol. 2004;2:E95.","journal-title":"PLoS Biol"},{"key":"8943_CR36","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0092-8674(00)81991-1","volume":"87","author":"M Zecca","year":"1996","unstructured":"Zecca M, Basler K, Struhl G. Direct and long-range action of a wingless morphogen gradient. Cell. 1996;87:833\u201344.","journal-title":"Cell"},{"key":"8943_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1242\/dev.118.2.401","volume":"118","author":"AH Brand","year":"1993","unstructured":"Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118:401\u201315.","journal-title":"Development"},{"key":"8943_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature04371","volume":"439","author":"CA Micchelli","year":"2006","unstructured":"Micchelli CA, Perrimon N. Evidence that stem cells reside in the adult Drosophila midgut epithelium. Nature. 2006;439:475\u20139.","journal-title":"Nature"},{"key":"8943_CR39","doi-asserted-by":"publisher","first-page":"e1006870","DOI":"10.1371\/journal.pgen.1006870","volume":"13","author":"A Tian","year":"2017","unstructured":"Tian A, Benchabane H, Wang Z, Zimmerman C, Xin N, Perochon J, et al. Intestinal stem cell overproliferation resulting from inactivation of the APC tumor suppressor requires the transcription cofactors Earthbound and Erect wing. PLoS Genet. 2017;13:e1006870.","journal-title":"PLoS Genet"},{"key":"8943_CR40","doi-asserted-by":"publisher","first-page":"e01998","DOI":"10.7554\/eLife.01998","volume":"3","author":"JL Stamos","year":"2014","unstructured":"Stamos JL, Chu ML, Enos MD, Shah N, Weis WI. Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6. eLife. 2014;3:e01998.","journal-title":"eLife"},{"key":"8943_CR41","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1021\/pr300155r","volume":"11","author":"X Huang","year":"2012","unstructured":"Huang X, Tian C, Liu M, Wang Y, Tolmachev AV, Sharma S, et al. Quantitative proteomic analysis of mouse embryonic fibroblasts and induced pluripotent stem cells using 16O\/18O labeling. J Proteome Res. 2012;11:2091\u2013102.","journal-title":"J Proteome Res"},{"key":"8943_CR42","doi-asserted-by":"crossref","unstructured":"Bhuvanalakshmi G, Gamit N, Patil M, Arfuso F, Sethi G, Dharmarajan A, et al. Stemness, pluripotentiality, and Wnt antagonism: sFRP4, a Wnt antagonist mediates pluripotency and stemness in glioblastoma. Cancers (Basel). 2018;11:25.","DOI":"10.3390\/cancers11010025"},{"key":"8943_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112912","volume":"409","author":"IA Yasmin","year":"2021","unstructured":"Yasmin IA, Mohana Sundaram S, Banerjee A, Varier L, Dharmarajan A, Warrier S. Netrin-like domain of sFRP4, a Wnt antagonist inhibits stemness, metastatic and invasive properties by specifically blocking MMP-2 in cancer stem cells from human glioma cell line U87MG. Exp Cell Res. 2021;409:112912.","journal-title":"Exp Cell Res"},{"key":"8943_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118854","volume":"265","author":"S Mandal","year":"2021","unstructured":"Mandal S, Gamit N, Varier L, Dharmarajan A, Warrier S. Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p. Life Sci. 2021;265:118854.","journal-title":"Life Sci"},{"key":"8943_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biocel.2019.01.016","volume":"109","author":"A Deshmukh","year":"2019","unstructured":"Deshmukh A, Arfuso F, Newsholme P, Dharmarajan A. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells. Int J Biochem Cell Biol. 2019;109:23\u201332.","journal-title":"Int J Biochem Cell Biol"},{"key":"8943_CR46","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","volume":"10","author":"P Marcato","year":"2011","unstructured":"Marcato P, Dean CA, Giacomantonio CA, Lee PW. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle. 2011;10:1378\u201384.","journal-title":"Cell Cycle"},{"key":"8943_CR47","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.neo.2015.07.006","volume":"17","author":"O Lyros","year":"2015","unstructured":"Lyros O, Rafiee P, Nie L, Medda R, Jovanovic N, Otterson MF, et al. Wnt\/beta-catenin signaling activation beyond robust nuclear beta-catenin accumulation in nondysplastic Barrett\u2019s esophagus: regulation via Dickkopf-1. Neoplasia. 2015;17:598\u2013611.","journal-title":"Neoplasia"},{"key":"8943_CR48","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.1093\/nar\/gkq363","volume":"38","author":"D Bottomly","year":"2010","unstructured":"Bottomly D, Kyler SL, McWeeney SK, Yochum GS. Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res. 2010;38:5735\u201345.","journal-title":"Nucleic Acids Res"},{"key":"8943_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cell.2006.08.036","volume":"127","author":"L Yang","year":"2006","unstructured":"Yang L, Lin C, Liu ZR. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin. Cell. 2006;127:139\u201355.","journal-title":"Cell"},{"key":"8943_CR50","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1038\/onc.2014.190","volume":"34","author":"HH Chen","year":"2015","unstructured":"Chen HH, Yu HI, Cho WC, Tarn WY. DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway. Oncogene. 2015;34:2790\u2013800.","journal-title":"Oncogene"},{"key":"8943_CR51","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1158\/1535-7163.MCT-18-1334","volume":"18","author":"A Capasso","year":"2019","unstructured":"Capasso A, Bagby SM, Dailey KL, Currimjee N, Yacob BW, Ionkina A, et al. First-in-Class phosphorylated-p68 inhibitor RX-5902 inhibits beta-catenin signaling and demonstrates antitumor activity in triple-negative breast cancer. Mol Cancer Ther. 2019;18:1916\u201325.","journal-title":"Mol Cancer Ther"},{"key":"8943_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0092-8674(01)00334-8","volume":"105","author":"BA Edgar","year":"2001","unstructured":"Edgar BA, Orr-Weaver TL. Endoreplication cell cycles: more for less. Cell. 2001;105:297\u2013306.","journal-title":"Cell"},{"key":"8943_CR53","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0140-6736(11)61847-3","volume":"379","author":"J Baselga","year":"2012","unstructured":"Baselga J, Bradbury I, Eidtmann H, Di Cosimo S, de Azambuja E, Aura C, et al. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial. Lancet. 2012;379:633\u201340.","journal-title":"Lancet"},{"key":"8943_CR54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tibs.2014.08.006","volume":"39","author":"M Bienz","year":"2014","unstructured":"Bienz M. Signalosome assembly by domains undergoing dynamic head-to-tail polymerization. Trends Biochem Sci. 2014;39:487\u201395.","journal-title":"Trends Biochem Sci"},{"key":"8943_CR55","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1126\/science.1137065","volume":"316","author":"J Bilic","year":"2007","unstructured":"Bilic J, Huang YL, Davidson G, Zimmermann T, Cruciat CM, Bienz M, et al. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science. 2007;316:1619\u201322.","journal-title":"Science"},{"key":"8943_CR56","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00018-010-0329-3","volume":"67","author":"C Niehrs","year":"2010","unstructured":"Niehrs C, Shen J. Regulation of Lrp6 phosphorylation. Cell Mol Life Sci. 2010;67:2551\u201362.","journal-title":"Cell Mol Life Sci"},{"key":"8943_CR57","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccr.2014.03.021","volume":"25","author":"S Su","year":"2014","unstructured":"Su S, Liu Q, Chen J, Chen J, Chen F, He C, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell. 2014;25:605\u201320.","journal-title":"Cancer Cell"},{"key":"8943_CR58","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/onc.2010.458","volume":"30","author":"XT Zhang","year":"2011","unstructured":"Zhang XT, Kang LG, Ding L, Vranic S, Gatalica Z, Wang ZY. A positive feedback loop of ER-alpha36\/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene. 2011;30:770\u201380.","journal-title":"Oncogene"},{"key":"8943_CR59","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1073\/pnas.1303671110","volume":"110","author":"JL Green","year":"2013","unstructured":"Green JL, La J, Yum KW, Desai P, Rodewald LW, Zhang X, et al. Paracrine Wnt signaling both promotes and inhibits human breast tumor growth. Proc Natl Acad Sci USA. 2013;110:6991\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8943_CR60","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1:313\u201323.","journal-title":"Cell Stem Cell"},{"key":"8943_CR61","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1038\/onc.2012.461","volume":"32","author":"J Zhang","year":"2013","unstructured":"Zhang J, Espinoza LA, Kinders RJ, Lawrence SM, Pfister TD, Zhou M, et al. NANOG modulates stemness in human colorectal cancer. Oncogene. 2013;32:4397\u2013405.","journal-title":"Oncogene"},{"key":"8943_CR62","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.canlet.2013.07.009","volume":"340","author":"Y Lu","year":"2013","unstructured":"Lu Y, Zhu H, Shan H, Lu J, Chang X, Li X, et al. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Cancer Lett. 2013;340:113\u201323.","journal-title":"Cancer Lett"},{"key":"8943_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7411","volume":"6","author":"U Basu-Roy","year":"2015","unstructured":"Basu-Roy U, Bayin NS, Rattanakorn K, Han E, Placantonakis DG, Mansukhani A, et al. Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells. Nat Commun. 2015;6:6411.","journal-title":"Nat Commun"},{"key":"8943_CR64","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11010-011-1148-z","volume":"362","author":"J Li","year":"2012","unstructured":"Li J, Li J, Chen B. Oct4 was a novel target of Wnt signaling pathway. Mol Cell Biochem. 2012;362:233\u201340.","journal-title":"Mol Cell Biochem"},{"key":"8943_CR65","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/stem.1182","volume":"30","author":"EE Ibrahim","year":"2012","unstructured":"Ibrahim EE, Babaei-Jadidi R, Saadeddin A, Spencer-Dene B, Hossaini S, Abuzinadah M, et al. Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms. Stem Cells. 2012;30:2076\u201387.","journal-title":"Stem Cells"},{"key":"8943_CR66","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1615\/ForumImmunDisTher.v1.i3.10","volume":"1","author":"Q Du","year":"2010","unstructured":"Du Q, Geller DA. Cross-regulation between Wnt and NF-kappaB signaling pathways. Immunopathol Dis Ther. 2010;1:155\u201381.","journal-title":"Immunopathol Dis Ther"},{"key":"8943_CR67","doi-asserted-by":"crossref","unstructured":"Diamond JRC P, Andreopoulou E, Gluck WL, Nanda R, Peterson C, Benaim E. Preliminary report of a phase 1b\/2a trial, an oral inhibitor of phosphorylated P68 (P-p68) which mediates \u03b2-catenin nuclear translocation in advanced triple-negative breast cancer (TNBC). J Clin Oncol. 2018;36:1097\u20131097.","DOI":"10.1200\/JCO.2018.36.15_suppl.1097"},{"key":"8943_CR68","doi-asserted-by":"publisher","first-page":"v83","DOI":"10.1093\/annonc\/mdx365.021","volume":"28","author":"J Diamond","year":"2017","unstructured":"Diamond J, Eckhardt G, Gluck L, Gutierrez M, Peterson C, Pila R, et al. Phase 1 study of RX-5902, a novel orally bioavailable inhibitor of phosphorylated P68, which prevents \u03b2-catenin translocation in advanced solid tumors. Ann Oncol. 2017;28:v83.","journal-title":"Ann Oncol"},{"key":"8943_CR69","doi-asserted-by":"crossref","unstructured":"Nagarkar-Jaiswal S, Lee PT, Campbell ME, Chen K, Anguiano-Zarate S, Gutierrez MC, et al. A library of MiMICs allows tagging of genes and reversible, spatial and temporal knockdown of proteins in Drosophila. eLife. 2015;4:e05338.","DOI":"10.7554\/eLife.05338"},{"key":"8943_CR70","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1091\/mbc.e08-01-0024","volume":"20","author":"KB Shpargel","year":"2009","unstructured":"Shpargel KB, Praveen K, Rajendra TK, Matera AG. Gemin3 is an essential gene required for larval motor function and pupation in Drosophila. Mol Biol Cell. 2009;20:90\u2013101.","journal-title":"Mol Biol Cell"},{"key":"8943_CR71","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1016\/j.jmb.2020.03.019","volume":"432","author":"N Bunnag","year":"2020","unstructured":"Bunnag N, Tan QH, Kaur P, Ramamoorthy A, Sung ICH, Lusk J, et al. An optogenetic method to study signal transduction in intestinal stem cell homeostasis. J Mol Biol. 2020;432:3159\u201376.","journal-title":"J Mol Biol"},{"key":"8943_CR72","doi-asserted-by":"publisher","first-page":"42502","DOI":"10.1074\/jbc.M112.365163","volume":"287","author":"A Banerjee","year":"2012","unstructured":"Banerjee A, Qian P, Wu ZS, Ren X, Steiner M, Bougen NM, et al. Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells. J Biol Chem. 2012;287:42502\u201315.","journal-title":"J Biol Chem"},{"key":"8943_CR73","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ymeth.2014.03.022","volume":"68","author":"CA Micchelli","year":"2014","unstructured":"Micchelli CA. Whole-mount immunostaining of the adult Drosophila gastrointestinal tract. Methods. 2014;68:273\u20139.","journal-title":"Methods"},{"key":"8943_CR74","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1083\/jcb.134.1.149","volume":"134","author":"HA Muller","year":"1996","unstructured":"Muller HA, Wieschaus E. armadillo, bazooka, and stardust are critical for early stages in formation of the zonula adherens and maintenance of the polarized blastoderm epithelium in Drosophila. J cell Biol. 1996;134:149\u201363.","journal-title":"J cell Biol"},{"key":"8943_CR75","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1242\/dev.128.11.2107","volume":"128","author":"NS Tolwinski","year":"2001","unstructured":"Tolwinski NS, Wieschaus E. Armadillo nuclear import is regulated by cytoplasmic anchor Axin and nuclear anchor dTCF\/Pan. Development (Camb, Engl). 2001;128:2107\u201317.","journal-title":"Development (Camb, Engl)"},{"key":"8943_CR76","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0092-8674(90)90451-J","volume":"63","author":"B Riggleman","year":"1990","unstructured":"Riggleman B, Schedl P, Wieschaus E. Spatial expression of the Drosophila segment polarity gene armadillo is posttranscriptionally regulated by wingless. Cell. 1990;63:549\u201360.","journal-title":"Cell"},{"key":"8943_CR77","doi-asserted-by":"publisher","first-page":"e18616","DOI":"10.1371\/journal.pone.0018616","volume":"6","author":"NA Kaplan","year":"2011","unstructured":"Kaplan NA, Colosimo PF, Liu X, Tolwinski NS. Complex interactions between GSK3 and aPKC in Drosophila embryonic epithelial morphogenesis. PLoS ONE. 2011;6:e18616.","journal-title":"PLoS ONE"},{"key":"8943_CR78","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1371\/journal.pone.0000009","volume":"1","author":"PF Colosimo","year":"2006","unstructured":"Colosimo PF, Tolwinski NS. Wnt, Hedgehog and junctional Armadillo\/beta-catenin establish planar polarity in the Drosophila embryo. PLoS ONE. 2006;1:e9.","journal-title":"PLoS ONE"},{"key":"8943_CR79","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1021\/acs.jctc.0c00744","volume":"16","author":"B Kohnke","year":"2020","unstructured":"Kohnke B, Kutzner C, Grubm\u00fcller H. A GPU-accelerated fast multipole method for GROMACS: performance and accuracy. J Chem Theory Comput. 2020;16:6938\u201349.","journal-title":"J Chem Theory Comput"},{"key":"8943_CR80","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller III","year":"2012","unstructured":"Miller BR III, McGee TD Jr., Swails JM, Homeyer N, Gohlke H, Roitberg AE. MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput. 2012;8:3314\u201321.","journal-title":"J Chem Theory Comput"},{"key":"8943_CR81","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","volume":"63","author":"DA Case","year":"2023","unstructured":"Case DA, Aktulga HM, Belfon K, Cerutti DS, Cisneros GA, Cruzeiro VWD, et al. AmberTools. J Chem Inf Model. 2023;63:6183\u201391.","journal-title":"J Chem Inf Model"},{"key":"8943_CR82","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11:3696\u2013713.","journal-title":"J Chem Theory Comput"},{"key":"8943_CR83","first-page":"7199","volume":"20","author":"LE Raguette","year":"2024","unstructured":"Raguette LE, Cuomo AE, Belfon KAA, Tian C, Hazoglou V, Witek G, et al. phosaa14SB and phosaa19SB: updated amber force field parameters for phosphorylated amino acids. J Chem Theory Comput. 2024;20:7199\u2013209.","journal-title":"J Chem Theory Comput"},{"key":"8943_CR84","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1021\/ct400146w","volume":"9","author":"P Li","year":"2013","unstructured":"Li P, Roberts BP, Chakravorty DK, Merz KM Jr. Rational design of particle Mesh Ewald compatible Lennard\u2013Jones parameters for +2 metal cations in explicit solvent. J Chem Theory Comput. 2013;9:2733\u201348.","journal-title":"J Chem Theory Comput"},{"key":"8943_CR85","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/jcc.10262","volume":"24","author":"KL Meagher","year":"2003","unstructured":"Meagher KL, Redman LT, Carlson HA. Development of polyphosphate parameters for use with the AMBER force field. J Comput Chem. 2003;24:1016\u201325.","journal-title":"J Comput Chem"},{"key":"8943_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.softx.2019.100241","volume":"10","author":"A Bernardi","year":"2019","unstructured":"Bernardi A, Faller R, Reith D, Kirschner KN. ACPYPE update for nonuniform 1\u20134 scale factors: conversion of the GLYCAM06 force field from AMBER to GROMACS. SoftwareX. 2019;10:100241.","journal-title":"SoftwareX"},{"key":"8943_CR87","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926\u201335.","journal-title":"J Chem Phys"},{"key":"8943_CR88","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1021\/jp8001614","volume":"112","author":"IS Joung","year":"2008","unstructured":"Joung IS, Cheatham TE III. Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. J Phys Chem B. 2008;112:9020\u201341.","journal-title":"J Phys Chem B"},{"key":"8943_CR89","doi-asserted-by":"crossref","unstructured":"Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys 2007;126:014101.","DOI":"10.1063\/1.2408420"},{"key":"8943_CR90","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981;52:7182\u201390.","journal-title":"J Appl Phys"},{"key":"8943_CR91","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.20033","volume":"55","author":"A Onufriev","year":"2004","unstructured":"Onufriev A, Bashford D, Case DA. Exploring protein native states and large-scale conformational changes with a modified generalized Born model. Proteins. 2004;55:383\u201394.","journal-title":"Proteins"},{"key":"8943_CR92","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","volume":"20","author":"J Weiser","year":"1999","unstructured":"Weiser J, Shenkin PS, Still WC. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J Comput Chem. 1999;20:217\u201330.","journal-title":"J Comput Chem"},{"key":"8943_CR93","doi-asserted-by":"publisher","first-page":"e0235343","DOI":"10.1371\/journal.pone.0235343","volume":"15","author":"R Raisner","year":"2020","unstructured":"Raisner R, Bainer R, Haverty PM, Benedetti KL, Gascoigne KE. Super-enhancer acquisition drives oncogene expression in triple negative breast cancer. PLoS ONE. 2020;15:e0235343.","journal-title":"PLoS ONE"},{"key":"8943_CR94","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"8943_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:R137.","journal-title":"Genome Biol"},{"key":"8943_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2019.33","volume":"6","author":"AA Perreault","year":"2019","unstructured":"Perreault AA, Sprunger DM, Venters BJ. Epigenetic and transcriptional profiling of triple negative breast cancer. Sci Data. 2019;6:190033.","journal-title":"Sci Data"},{"key":"8943_CR97","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"Consortium EP.","year":"2012","unstructured":"Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57\u201374.","journal-title":"Nature"},{"key":"8943_CR98","doi-asserted-by":"publisher","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","volume":"46","author":"CA Davis","year":"2018","unstructured":"Davis CA, Hitz BC, Sloan CA, Chan ET, Davidson JM, Gabdank I, et al. The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018;46:D794\u2013D801.","journal-title":"Nucleic Acids Res"},{"key":"8943_CR99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.06.007","volume":"518","author":"V Koh","year":"2021","unstructured":"Koh V, Chakrabarti J, Torvund M, Steele N, Hawkins JA, Ito Y, et al. Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids. Cancer Lett. 2021;518:59\u201371.","journal-title":"Cancer Lett"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08943-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08943-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08943-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:02:57Z","timestamp":1785780177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08943-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8943"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08943-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research funding from Rexahn Pharmaceuticals, Inc. to YBL and DJK. YBL and DJK are employees of Rexahn Pharmaceuticals, Inc. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"For animal studies, the care and use of animals were in accordance with the guidelines set by the Institutional Animal Care and Use Committee (IACUC) at the National Cancer Center Singapore.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"673"}}